Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Accepted on 30 May 2025

Comparing Tacrolimus Level Monitoring in Peripheral Blood Mononuclear Cells and Whole Blood Within One Year After Kidney Transplantation: A Single-Center, Prospective, Observational Study

in Drugs Outcomes Research and Policies

Jia You
Rui Chen
Chai Yuhui
Xue Wang
Wenmin Xie
Yunyun Yang
Kaile Zheng
Lizhi Chen
Zhuo Wang
Xuebin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1622702

262 views

Brief Research Report

Accepted on 30 May 2025

Cost-Analysis of Universal Decolonization with Pure Hypochlorous Acid and Mupirocin to Reduce MRSA Infections in Burn Intensive Care Unit Patients

in Drugs Outcomes Research and Policies

Peter J Mallow
Debashish Chakravarthy
Kevin Foster

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1606589

114 views

Systematic Review

Accepted on 30 May 2025

Effects of Anti-Osteoporotic Drugs in Patients with Chronic Kidney Disease: A Systemic Review and Network Meta-analysis of bone mineral density, clinical fracture rate and renal function

in Drugs Outcomes Research and Policies

Chih-Hsuan Wung
Hao-Yu Liu
Tsung-Ting Tsai
Jia-Jin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1569744

Review

Published on 30 May 2025

Oxaliplatin-induced neuropathic pain in cancer: animal models and related research progress

in Drugs Outcomes Research and Policies

Yuxin Jiang
Jie Shi
Wenping Wang
Haozhe Piao
Huini Yao
Jun Yu
Zhenzhu Zhai
Qian Liu
Ningxin Li
Jiaqing Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1609791

530 views

Original Research

Published on 30 May 2025

Adverse events in the neonatal intensive care unit identified by triggers

in Drugs Outcomes Research and Policies

Fabiana Bragança Albanese
Deise de Souza Ventura
Maurício Wesley Perroud
Rafael Nogueira de Souza
Mariana Vieira Morau
Marília Berlofa Visacri
Patricia Moriel

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1539687

152 views

Original Research

Published on 30 May 2025

Analyzing collaboration dynamics in new drug R&D: A case study of two lipid-lowering drugs

in Drugs Outcomes Research and Policies

Nan Zhang
Huaqing Guo
Mengchao Zhang
Chen Wang
Ruonan Tian
Yan Shi
Zhiguang Duan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516882

213 views

Correction

Accepted on 28 May 2025

Hemoglobin-to-Red Blood Cell Distribution Width Ratio as a Protective Factor Against Coronary Artery Disease: A Cross-Sectional Analysis of NHANES (2011-2018)

in Drugs Outcomes Research and Policies

Xin-da Wang
Chaoya Li
Jia Hu
Fen Cao
Li Zhu
Yongzhi Zhu
Zhongzheng Wen
Liu Jun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1634607

Original Research

Published on 27 May 2025

Evaluation of physicians’ opioid prescribing practices, attitudes, and interactions with other healthcare professionals in optimizing opioid prescribing in Pakistan

in Drugs Outcomes Research and Policies

Hafsa Arshad
Ali Hassan Gillani
Muhammad Arshed
Yu Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1491764

461 views

Original Research

Accepted on 26 May 2025

Effectiveness of Clopidogrel vs Ticagrelor based on the ABCD-GENE Score in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention

in Drugs Outcomes Research and Policies

Xiaotong Xu
Kun Na
Miaohan Qiu
Zizhao Qi
Xueqing Yang
Jing Li
Kai Xu
Xiaozeng Wang
Yi Li
Yaling Han

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1606327

164 views

Original Research

Accepted on 23 May 2025

Association of morphine vs fentanyl prescription dispensation with adverse clinical outcomes

in Drugs Outcomes Research and Policies

Carlen Reyes
Maria Antonia Pou
Cesar Diaz-Torne
Cristina Carbonell-Abella
Carlos Brotons
Daniel Martinez-Laguna

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579634

Original Research

Published on 23 May 2025

Development and validation of a machine-learning model for the risk of potentially inappropriate medications in elderly stroke patients

in Drugs Outcomes Research and Policies

Xiaodan Yang
Qianqian Ye
Mengxiang Zhang
Yuewei Xu
Manqin Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565420

614 views

Systematic Review

Published on 23 May 2025

Cost-effectiveness of dapagliflozin for the treatment of heart failure: a systematic review

in Drugs Outcomes Research and Policies

Zehui Jiang
Dong xiao Chen
Cai Xiao
Ying Fu
Jun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572289

433 views

Original Research

Published on 23 May 2025

A sex-sensitive LC-MS/MS method with isotopic internal standard for prazosin bioequivalence: bridging precision medicine and generic drug policy in China

in Drugs Outcomes Research and Policies

Hui Chen
Junping Guo
Zhenyu Zhu
Xiaomei Huang
Jincai Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592731

414 views

Original Research

Published on 23 May 2025

Prediction of early mucosal healing of Crohn’s disease after treatment with biologics- a novel nomogram based on radiomics and clinical risk factors

in Drugs Outcomes Research and Policies

Linlin Huang
Hui Li
Shuo Wang
Ying Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586300

340 views

Original Research

Published on 23 May 2025

Perioperative dexmedetomidine effects on delirium in elderly patients after noncardiac surgery: A retrospective propensity score analysis

in Drugs Outcomes Research and Policies

Hong-Wei Wang
Qin-Jun Chu
Ze-Fei Zhu
Ming Cheng
Ze-Ping Li
Liang Zang
Long He
Lin-Na Chen
Qian He
Jian-Jun Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578233

314 views

Original Research

Published on 22 May 2025

Cost-effectiveness analysis of tislelizumab plus chemotherapy as first-line treatment for HER2-negative advanced gastric or gastro-oesophageal junction adenocarcinoma

in Drugs Outcomes Research and Policies

Liangliang Zou
Guilan Guo
Yufan Huang
Cuihua Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1500729

506 views